4.7.1. Insomnia

 - For Kent and Medway PRGC Policy recommendation on Melatonin for Jet Lag
- For Kent & Medway Guideline on the Use of Melatonin for the Management of Sleep Disorders in Children, Adolescents, and Adults 
- For Melatonin Prescribing Checklist      
Click Here

For Controlled drugs/benzodiazepine prescribing patient treatment
agreement  Click Here

Daridorexant
Daridorexant should be prescribed in line with this Kent and Medway guidance
- Daridorexant Prescribing Guidance (4. Nervous system - guidance page) Click Here 
- Daridorexant for treating long-term insomnia NICE TA 922

Daridorexant is recommended for treating insomnia in adults with symptoms lasting for 3 nights or more per week for at least 3 months in line with the NHS Kent and Medway guidance. The length of treatment should be as short as possible. Treatment with Daridorexant should be assessed within 3 months of starting and should be stopped in people whose long-term insomnia has not responded adequately. If treatment is continued, assess whether it is still working at regular intervals. The initiating clinician is responsible for the 3 month assessment of efficacy.